Wall Street finished a small increase with the health


by Noel Randewich and April Joyner

NEW YORK (Reuters) – The New York stock Exchange finished Friday slightly higher, except for the Nasdaq to be almost stable, supported among others by the health sector at the end of a week which enabled him to win more than 2%.

The Dow Jones has taken 91,64 points (0.37 percent), 24.831,17. The Standard & Poor’s 500, wider and main reference of the investors, has grappillé the 4.65 points, or 0.17%, to 2.727,72. The Nasdaq Composite, technology-intensive, has completed on a decline of 2,092 points, or 0.03%, to 7.402,883.

On the week, however, marked by the announcement by Donald Trump of the restoration of u.s. sanctions against Iran, the Dow gained 2.3%, the S&P-500 2.4% and the Nasdaq by 2.7%. It is of the strongest progressions weekly since march for the Dow and the S&P-500.

This trend could be called on to extend.

As the S&P-500 the day before, the Dow fell Friday for the first time since April 18, above its moving average of 100 days, a motion that a portion of the investors consider it as a positive signal in the short term.

While the quarterly earnings season is virtually over, the companies in the S&P-500 appear to have increased their earnings per share by 26%, according to data from Thomson Reuters I/B/E/S.

With the increase in forecasts of profits and the decline in equity prices since January, the S&P-500 is trading more than 16 times the expected benefits, its ratio is the lowest for the past two years, according to Thomson Reuters Datastream.

“We have a fundamental, very strong from the point of view of the profits and the valuations seem a little more reasonable than they were at the end of last year,” judge, Bill Northey, vice-president of U. S. Bank Wealth Management.

The health sector is shown with a gain of 1.47% at the end of a session volatile due to a speech by Donald Trump on the price of prescription drugs in the United States.


The american president has promised to increase the competition and remove the “interim” become “very rich” in the pharmaceutical industry. Investors have, however, noted that it announced no action direct and immediate to lower the cost of drugs.

Merck (NYSE:MRK) has gained 2.8 percent, Johnson & Johnson 1.51 per cent and Pfizer (NYSE:PFE) to 1.31%.

The Nasdaq biotechnology is awarded 2,68%, including an increase of 6.24% for Regeneron, the best performance in the S&P-500.

Nvidia has lost 2.15% after the publication of its quarterly results. If the group is known primarily for its graphics processors, the market was expecting, especially its sales in the data centers, however, it has emerged as the consensus.

The decline of Nvidia has weighed on the sector of semi-conductors (of-0.75%) and the S&P high technology (-0,32%), lower after six sessions of progression.

This last has still been hit hard by the plunge 33,11% of Symantec. The specialist in cyber security, which manufactures the Norton antivirus software, has announced that an internal investigation underway could delay the publication of its annual accounts.

Apple (NASDAQ:AAPL) has also contributed to the decline sector. The title of the manufacturer of the iPhone has lost 0,38%, after nine consecutive sessions of increases that have matched the market capitalization of the firm at the apple of the 1.000 billion dollars.

In contrast, Verizon (NYSE:VZ) gained 3%, the largest increase in the Dow Jones to Merck, after the recovery of the recommendation from JPMorgan (NYSE:JPM) to “overweight”.

About 5.8 billion shares were traded during the session on different u.s. markets, a volume lower than the average of 6.6 billion over the 20 previous sessions.

The dollar has weakened for a third day in a row facing a basket of reference currencies (0.1%) and the euro rose to 1,1942 dollar (+0,25%). Investors take their profits after the recent rise in the greenback caused by the widening of the yield spread of sovereign bonds between the United States and the european countries, in particular Germany.

The yield on 10-year Treasuries, however, is almost unchanged on Friday, 2.97%.

The price of oil fell at the end of a week that took them back to the highest of the three and a half years because of the geopolitical tensions around Iran. The light crude american has lost almost 1% below $ 71 / barrel and Brent is back to the 77 dollars.

(With Sruthi Shankar in Bangalore; Bertrand Boucey for the French service)

Like this post? Please share to your friends:
Leave a Reply